Small vessel coronary artery disease: How small can we go with myocardial revascularization?
Maciej T WybraniecPaweł BańkaTomasz BochenekTomasz RolederKatarzyna Mizia-StecPublished in: Cardiology journal (2020)
The issue of small coronary artery atherosclerosis represents an intriguing aspect of coronary artery disease, which is related with higher rates of peri- and post-procedural complications and impaired long-term outcome. This problem is further complicated by the unclear definition of small coronary vessel. Recent randomized controlled trials have provided new data on possible novel interventional treatment of small coronary vessels with drug-coated balloons instead of traditional new-generation drug-eluting stent implantation. Also, the conservative management represents a therapeutic option in light of the results of the recent ISCHEMIA trial. The current article provides an overview of the most appropriate definition, interventional management, and prognosis of small coronary artery atherosclerosis.
Keyphrases
- coronary artery
- coronary artery disease
- pulmonary artery
- percutaneous coronary intervention
- randomized controlled trial
- cardiovascular disease
- coronary artery bypass grafting
- clinical trial
- heart failure
- emergency department
- study protocol
- electronic health record
- risk factors
- machine learning
- artificial intelligence
- phase ii
- phase iii
- pulmonary arterial hypertension
- aortic valve
- adverse drug